These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
561 related articles for article (PubMed ID: 37560911)
1. Association of the low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and major adverse cardiac and cerebrovascular events in patients with coronary heart disease undergoing percutaneous coronary intervention: a cohort study. Ren X; Wang X Curr Med Res Opin; 2023 Sep; 39(9):1175-1181. PubMed ID: 37560911 [TBL] [Abstract][Full Text] [Related]
2. [The impact of LDL-C/HDL-C ratio on severity of coronary artery disease and 2-year outcome in patients with premature coronary heart disease: results of a prospective, multicenter, observational cohort study]. Xu JJ; Chen J; Liu YX; Song Y; Jiang L; Yan SD; Guo WY; Yao Y; Jia SD; Yuan DS; Wang PZ; Li JX; Zhao XY; Liu ZY; Yuan JQ Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):702-708. PubMed ID: 37460423 [No Abstract] [Full Text] [Related]
3. Effect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary intervention. Lee EY; Yang Y; Kim HS; Cho JH; Yoon KH; Chung WS; Lee SH; Chang K Atherosclerosis; 2018 Dec; 279():1-9. PubMed ID: 30359786 [TBL] [Abstract][Full Text] [Related]
4. Relationship between small dense low density lipoprotein and cardiovascular events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Zhang J; He L BMC Cardiovasc Disord; 2021 Apr; 21(1):169. PubMed ID: 33845772 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the LDL-C/HDL-C ratio as a predictor of one year clinical outcomes in patients with acute coronary syndromes after percutaneous coronary intervention and drug-eluting stent implantation. Zhong Z; Hou J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P Lipids Health Dis; 2019 Feb; 18(1):40. PubMed ID: 30711009 [TBL] [Abstract][Full Text] [Related]
6. Very high HDL-C (high-density lipoprotein cholesterol) is associated with increased cardiovascular risk in patients with NSTEMI (non-ST-segment elevation myocardial infarction) undergoing PCI (percutaneous coronary intervention). Chen L; Zhao Y; Wang Z; Wang Y; Bo X; Jiang X; Hao C; Ju C; Qu Y; Dong H BMC Cardiovasc Disord; 2023 Jul; 23(1):357. PubMed ID: 37461001 [TBL] [Abstract][Full Text] [Related]
7. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL. Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484 [TBL] [Abstract][Full Text] [Related]
8. The analysis of the lipid levels in patients with coronary artery disease after percutaneous coronary intervention: a one-year follow-up observational study. Qiu W; Chen J; Huang X; Guo J Lipids Health Dis; 2020 Jul; 19(1):163. PubMed ID: 32631347 [TBL] [Abstract][Full Text] [Related]
9. Influence of LDL-Cholesterol Lowering on Cardiovascular Outcomes in Patients With Diabetes Mellitus Undergoing Coronary Revascularization. Farkouh ME; Godoy LC; Brooks MM; Mancini GBJ; Vlachos H; Bittner VA; Chaitman BR; Siami FS; Hartigan PM; Frye RL; Boden WE; Fuster V J Am Coll Cardiol; 2020 Nov; 76(19):2197-2207. PubMed ID: 33153578 [TBL] [Abstract][Full Text] [Related]
10. Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. Liu J; Oorloff MD; Nadella A; Guo P; Ye M; Wang X; Zhao H Lipids Health Dis; 2024 Oct; 23(1):324. PubMed ID: 39354522 [TBL] [Abstract][Full Text] [Related]
11. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases. Cai HJ; Li ZX; Yang SM Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460 [TBL] [Abstract][Full Text] [Related]
12. Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control. Carey VJ; Bishop L; Laranjo N; Harshfield BJ; Kwiat C; Sacks FM Am J Cardiol; 2010 Sep; 106(6):757-63. PubMed ID: 20816113 [TBL] [Abstract][Full Text] [Related]
13. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. Arsenault BJ; Rana JS; Stroes ES; Després JP; Shah PK; Kastelein JJ; Wareham NJ; Boekholdt SM; Khaw KT J Am Coll Cardiol; 2009 Dec; 55(1):35-41. PubMed ID: 20117361 [TBL] [Abstract][Full Text] [Related]
14. Impact of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio on long-term outcome in patients undergoing percutaneous coronary intervention. Matsumoto I; Miyake Y; Mizukawa M; Takagi Y Circ J; 2011; 75(4):905-10. PubMed ID: 21325724 [TBL] [Abstract][Full Text] [Related]
15. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study. Muntner P; Lee F; Astor BC Am J Med Sci; 2011 Mar; 341(3):173-80. PubMed ID: 21042169 [TBL] [Abstract][Full Text] [Related]
16. The prognostic role of the low and very low baseline LDL-C level in outcomes of patients with cardiac revascularization; comparative registry-based cohort design. Rezaee M; Fallahzadeh A; Sheikhy A; Ajam A; Sadeghian S; Bsc MP; Shirzad M; Mansourian S; Bagheri J; Hosseini K J Cardiothorac Surg; 2023 Jul; 18(1):240. PubMed ID: 37507734 [TBL] [Abstract][Full Text] [Related]
17. Statin treatment improves plasma lipid levels but not HDL subclass distribution in patients undergoing percutaneous coronary intervention. Tian L; Chen Y; Li C; Zeng Z; Xu Y; Long S; Fu M Lipids; 2013 Feb; 48(2):127-37. PubMed ID: 23275076 [TBL] [Abstract][Full Text] [Related]
18. The predictive value of atherogenic index of plasma for cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention with LDL-C below 1.8mmol/L. Wang Y; Wang S; Sun S; Li F; Zhao W; Yang H; Wu X Cardiovasc Diabetol; 2023 Jun; 22(1):150. PubMed ID: 37365588 [TBL] [Abstract][Full Text] [Related]
19. Paradoxical Long-Term Impact Between Serum Apolipoprotein E and High-Density Lipoprotein Cholesterol in Patients Undergoing Percutaneous Coronary Intervention. Fukase T; Dohi T; Nishio R; Takeuchi M; Takahashi N; Chikata Y; Endo H; Doi S; Nishiyama H; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T J Atheroscler Thromb; 2023 Jun; 30(6):611-623. PubMed ID: 35934781 [TBL] [Abstract][Full Text] [Related]
20. Low HDL-C predicts risk and PCI outcomes in the Han Chinese population. Lu Q; Tian G; Zhang Y; Lu M; Lin X; Ma A Atherosclerosis; 2013 Jan; 226(1):193-7. PubMed ID: 23107044 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]